Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection.
Morten HedetoftMarco Bo HansenMartin Bruun MadsenJulia Sidenius JohansenOle HyldegaardPublished in: BMC infectious diseases (2021)
High plasma YKL-40 to be associated with disease severity, renal-replacement therapy and risk of death in patients with NSTI. However, YKL-40 is not an independent predictor of 30-day mortality.